Letter | Published:

Neurotoxicity of a prion protein fragment

Naturevolume 362pages543546 (1993) | Download Citation

Subjects

Abstract

THE cellular prion protein (PrPc) is a sialoglycoprotein of Mr 33–35K that is expressed predominantly in neurons1–3. In transmissible and genetic neurodegenerative disorders such as scrapie of sheep, spongiform encephalopathy of cattle and Creutzfeldt–Jakob or Gerstmann–Sträussler–Scheinker diseases of humans4,5, PrPc is converted into an altered form (termed PrPSc) which is distinguishable from its normal homologue by its relative resistance to protease digestion6–8. PrPSc accumulates in the central nervous system of affected individuals8,9, and its protease-resistant core aggregates extracellularly into amyloid fibrils10–12. The process is accompanied by nerve cell loss, whose pathogenesis and molecular basis are not understood. We report here that neuronal death results from chronic exposure of primary rat hippocampal cultures to micromolar concentrations of a peptide corresponding to residues 106–126 of the amino-acid sequence deduced from human PrP complementary DNA. DNA fragmentation of degenerating neurons indicates that cell death occurred by apoptosis. The PrP peptide 106–126 has a high intrinsic ability to polymerize into amyloid-like fibrils in vitro. These findings indicate that cerebral accumulation of PrPSc and its degradation products may play a role in the nerve cell degeneration that occurs in prion-related encephalopathies.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Oesch, B. et al. Cell 40, 735–746 (1985).

  2. 2

    Chesebro, B. et al. Nature 315, 331–333 (1985).

  3. 3

    Kretzschmar, H. A., Prusiner, S. B., Stowring, L. E. & DeArmond, S. J. Am. J. Path. 122, 1–5 (1986).

  4. 4

    Gajdusek, D. C. in Virology (eds Field, B. N. et al.) 2289–2324 (Raven, New York, 1990).

  5. 5

    Prusiner, S. B. Science 252, 1515–1522 (1991).

  6. 6

    Bolton, D. C., McKinley, M. P. & Prusiner, S. B. Science 218, 1309–1311 (1982).

  7. 7

    Prusiner, S. B. et al. Biochemistry 21, 6942–6950 (1982).

  8. 8

    McKinley, M. P., Bolton, D. C. & Prusiner, S. B. Cell 35, 57–62 (1983).

  9. 9

    Meyer, R. K. et al. Proc. natn. Acad. Sci. U.S.A. 83, 2310–2314 (1986).

  10. 10

    Prusiner, S. B. et al. Cell 35, 349–358 (1983).

  11. 11

    DeArmond, S. J. et al. Cell 41, 221–235 (1985).

  12. 12

    Tagliavini, F. et al. EMBO J. 10, 513–519 (1991).

  13. 13

    Yankner, B. A., Duffy, L. K. & Kirschner, D. A. Science 250, 279–282 (1990).

  14. 14

    Kowall, N. W. et al. Proc. natn. Acad. Sci. U.S.A. 88, 7247–7251 (1991).

  15. 15

    Wyllie, A. H., Kerr, F. F. R. & Currie, A. R. Int. Rev. Cytol. 68, 251–306 (1980).

  16. 16

    Server, A. C. & Mobley, W. C. in: The Molecular Basis of Cell Death (eds Tomei, L. D. & Cope, F. O.) 263–277 (Cold Spring Harbor Laboratory Press, New York, 1991).

  17. 17

    Martin, S. J., Lennon, S. V., Bonham, A. M. & Cotter, T. G. J. Immun. 145, 1859–1867 (1990).

  18. 18

    Wyllie, A. H. Nature 284, 555–556 (1980).

  19. 19

    Clemens, J. A. & Stephenson, D. T. Neurobiol. Aging 13, 581–586 (1992).

  20. 20

    Emre, M., Geula, C., Ransil, B. J. & Mesulam, M. M. Neurobiol. Aging 13, 553–559 (1992).

  21. 21

    Price, D., Borchelt, D. R., Walker, L. C. & Sisodia, S. Neurobiol. Aging 13, 623–625 (1992).

  22. 22

    Pike, V. C. J., Walencewicz, A. J., Glabe, C. G. & Cotman, C. W. Brain Res. 563, 311–314 (1991).

  23. 23

    Tagliavini, F. et al. Soc. Neurosci. Abs. 18, 520.13 (1992).

  24. 24

    Bruce, M. E., McBride, P. A. & Farquhar, C. F. Neurosci. Lett. 102, 1–6 (1989).

  25. 25

    De Armond, S. J. et al. Neurology 37, 1271–1280 (1987).

  26. 26

    Giaccone, G. et al. Proc. natn. Acad. Sci. U.S.A. 89, 9349–9353 (1992).

  27. 27

    Montpetit, M. K., Lawless, K. R. & K. R. & Tenniswood, P. R. Prostrate 8, 25–31 (1986).

  28. 28

    Leger, J., Le Guellec, R. & Tenniswood, P. R. Prostrate 13, 131–142 (1988).

  29. 29

    Bettuzzi, S., Hilpakka, R. A., Gilna, P. & Liao, S. Biochem. J. 257, 293–296 (1989).

  30. 30

    Buttyan, R. in The Molecular Basis of Cell Death (eds Tomei, L. D. & Cope, F. O.) 157–173 (Cold Spring Harbor Laboratory Press, New York, 1991).

  31. 31

    Duguid, J. R., Bohmont, C. W., Liu, N. & Tourtellote, W. W. Proc. natn. Acad Sci. U.S.A. 86, 7260–7264 (1989).

  32. 32

    Forloni, G., Chiesa, R., Angeretti, N. & Smiroldo, S. Soc. Neurosci. Abs. 18, 601.16 (1992).

  33. 33

    Forloni, G. et al. Molec. Brain Res. 16, 128–134 (1992).

  34. 34

    Aggarwal, B. B., Moffat, B. & Harkins, R. N. J. biol. Chem. 259, 686–691 (1984).

  35. 35

    Fraser, P. E., Nguyen, W. K., Surewicz, W. D. & Kirschner, D. A. Biophys. J. 60, 1190–1201 (1991).

Download references

Author information

Affiliations

  1. Istituto di Ricerche Farmacologiche 'Mario Negri', Via Eritrea 62, 20157, Milano, Italy

    • Gianluigi Forloni
    • , Nadia Angeretti
    • , Roberto Chiesa
    • , Enrico Monzani
    •  & Mario Salmona
  2. Istituto Nazionale Neurologico 'Carlo Besta', 20133, Milano, Italy

    • Orso Bugiani
    •  & Fabrizio Tagliavini

Authors

  1. Search for Gianluigi Forloni in:

  2. Search for Nadia Angeretti in:

  3. Search for Roberto Chiesa in:

  4. Search for Enrico Monzani in:

  5. Search for Mario Salmona in:

  6. Search for Orso Bugiani in:

  7. Search for Fabrizio Tagliavini in:

About this article

Publication history

Received

Accepted

Issue Date

DOI

https://doi.org/10.1038/362543a0

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.